MedTrace Logo

Measuring the Impact of Real Time fMRI Neurofeedback in Borderline Personality Disorder

NCT04306341 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2023-05-22

No results posted yet for this study

Summary

This study will test the impacts of real time fMRI neurofeedback in patients with Borderline Personality Disorder. This is a pilot study in a small number of people enrolled in clinical programs at Yale New Haven Hospital.

Conditions

  • Borderline Personality Disorder

Interventions

BEHAVIORAL

real time fMRI neurofeedback

Participants will use real time feedback about their amygdala activity to learn to decrease amygdala activity.

Sponsors & Collaborators

  • AE Foundation

    collaborator OTHER

  • Central Institute of Mental Health, Mannheim

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • Sarah K Fineberg, MD PhD · Yale University

  • Michelle Hampson, PhD · Yale University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-15
Primary Completion
2022-10-07
Completion
2022-10-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04306341 on ClinicalTrials.gov